| Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study | Diabetologia | 2020 | 442 |
| Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164 | Journal of Clinical Oncology | 2020 | 315 |
| Insertions and Duplications in the Polyproline Region of the Hepatitis E Virus | Frontiers in Microbiology | 2020 | 199 |
| Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study | Journal of Clinical Oncology | 2020 | 160 |
| Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes | New England Journal of Medicine | 2020 | 160 |
| Sex differences in metabolic regulation and diabetes susceptibility | Diabetologia | 2020 | 148 |
| Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19 | Blood | 2020 | 147 |
| The official French guidelines to protect patients with cancer against SARS-CoV-2 infection | Lancet Oncology, The | 2020 | 107 |
| Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial | Lancet Oncology, The | 2020 | 77 |
| Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629) | Journal of Clinical Oncology | 2020 | 69 |
| Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials | JAMA Neurology | 2020 | 61 |
| A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis | Blood | 2020 | 59 |
| Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry | Circulation | 2020 | 59 |
| Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma | Blood Advances | 2020 | 58 |
| Vemurafenib in non-small-cell lung cancer patients with BRAF and BRAF mutations | Annals of Oncology | 2020 | 57 |
| ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children | Journal of the European Academy of Dermatology and Venereology | 2020 | 56 |
| Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection | Journal of Neuroradiology | 2020 | 55 |
| Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS | Journal of Hepatology | 2020 | 52 |
| cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing | Nature Genetics | 2020 | 52 |
| Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis | American Journal of Respiratory and Critical Care Medicine | 2020 | 49 |
| Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series | British Journal of Haematology | 2020 | 48 |
| Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci | Molecular Psychiatry | 2020 | 45 |
| COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network | Journal of Neurology, Neurosurgery and Psychiatry | 2020 | 44 |
| Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial | Annals of Internal Medicine | 2020 | 44 |
| French consensus on management of head and neck cancer surgery during COVID-19 pandemic | European Annals of Otorhinolaryngology, Head and Neck Diseases | 2020 | 42 |
